AtaiBeckley Inc. - Common Stock (NQ:ATAI)

7.350 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

31 32 Next >

Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026 ↗

March 24, 2023

Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:

Via Benzinga

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

March 24, 2023

From atai Life Sciences

Via GlobeNewswire

GH Research, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 23, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 22, 2023 ↗

March 22, 2023

Via Benzinga

The Latest Analyst Ratings for ATAI Life Sciences ↗

March 07, 2023

Via Benzinga

Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts ↗

March 06, 2023

Atai Life Sciences has just announced 30% job cuts. Here's how investors should be interpreting the Atai layoffs as ATAI stock rises.

Via InvestorPlace

Atai Life Sciences: Long On Money; Short On Success ↗

March 06, 2023

A review of Atai Life Sciences' latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock over the next 12 months.

Via Talk Markets

Psychedelic Stock Gainers And Losers From March 21, 2023 ↗

March 21, 2023

Via Benzinga

EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion ↗

March 21, 2023

This is the third article of a three-part series, you can find the first and

Via Benzinga

Psychedelic Stock Gainers And Losers From March 20, 2023 ↗

March 20, 2023

Via Benzinga

An Update On The Performance Of The 7 Largest Psychedelic Stocks ↗

March 19, 2023

The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the...

Via Talk Markets

The "Rags-To-Riches" Portfolio: An Update ↗

March 18, 2023

Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023.

Via Talk Markets

Psychedelic Stock Gainers And Losers From March 17, 2023 ↗

March 17, 2023

Via Benzinga

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 16, 2023

Via Benzinga

Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

March 15, 2023

Via Benzinga

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

March 14, 2023

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 13, 2023

Via Benzinga

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗

March 13, 2023

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event ↗

March 13, 2023

The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...

Via Benzinga

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

March 10, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 9, 2023 ↗

March 09, 2023

Via Benzinga

Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

March 08, 2023

Via Benzinga

Cybin, GH Research Among Top Psychedelic Movers Of Today ↗

March 07, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 6, 2023 ↗

March 06, 2023

Via Benzinga

Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce ↗

March 06, 2023

The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant...

Via Benzinga

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗

March 06, 2023

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

Via Benzinga

atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates

March 06, 2023

From atai Life Sciences

Via GlobeNewswire

Cybin, GH Research Among Top Psychedelic Movers Of Today ↗

March 03, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From March 2, 2023 ↗

March 02, 2023

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.